DoD: Acquisition Shows Improvement (But Still Needs It)
Client Alert | less than 1 min read | 10.27.16
On October 24, 2016, DoD released its annual report on the performance of the defense acquisition system – the fourth in a series continuing a “long-term effort to bring data-driven decision making to acquisition policy.” Generally, the report discusses many areas in which acquisition has improved (e.g., cost control) or is doing better than perceived (e.g., high-level program requirements, acquisition cycle times, private sector profitability), but it also highlights areas where improvement is needed (e.g., competition rates (which fell in FY 2015) and utilization of small business subcontractors (which “has been declining since FY 2010”)).
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
